An Improved and Updated Version of the Compact Procedure for the Evaluation of P450-Mediated Chemical Activation

References

• Lewis D. F. V., Langley G. R. A validation study of the COMPACT and Hazard expert techniques with 40 chemicals. Mutat. Res. 1996; 469: 157–174
   Google Scholar
• Lewis D. F. V. The Cytochromes P450: Structure, Function and Mechanism. Taylor and Francis, London 1996
   Google Scholar
• Lewis D. F. V. COMPACT and the importance of frontier orbitals in toxicity mediated by the cytochrome P450 mono-oxygenase system. Toxicol. Model. 1995; 1: 85–97
   Google Scholar
• Lewis D. F. V., Moereels H., Lake B. G., Ioannides C., Parke D. V. Molecular modelling of enzymes and receptors involved in carcinogenesis: QSARs and COMPACT-3D. Drug Metab. Rev. 1994; 26: 261–285
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Molecular modelling of cytochrome P4501: A putative access channel explains differences in induction potency between the isomers benzo(a)pyrene and benzo(e)pyrene and 2- and 4-acetylaminofluorene. Toxicol. Lett. 1994; 71: 235–243
   PubMed Web of Science ®Google Scholar
• Ioannides C., Cheung Y.-L., Wilson J. P., Lewis D. F. V., Gray T. J. B. Importance of cytochrome P450 induction in chemical carcinogenesis: The case for 2- and 4-acetylaminofluorene. Chem. Res. Toxicol. 1993; 6: 535–541
   PubMedGoogle Scholar
• Boyd G. W., Coombs M. M., Ioannides C. CYP1 induction, binding to the hepatic aromatic hydrocarbon receptor and mutagenicity of a series of 11-alkoxy cyclopenta[a]phenanthren-17-ones: A structure activity relationship. Toxicology 1995; 95: 27–35
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Quantitative structure-activity relationships in substrates, inducers and inhibitors of cytochromes P4501 (CYP1). Drug Metab. Rev. 1997; 29: 589–650
   PubMed Web of Science ®Google Scholar
• Roffey S. J. Structure-activity relationships in the metabolism of a series of tertiary amines by cytochrome P450. Ph.D. thesis, University of Surrey. 1993
   Google Scholar
• Lewis D. F. V., Lake B. G. Molecular modelling of CYP2B isoforms and their interaction with substrates, inhibitors and redox components. Xenobiotica 1997; 27: 443–478
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Molecular modelling of cytochromes P450. Computer-Assisted Lead Finding and Optimization, H. van de Waterbeemd, B. Testa, G. Folkers. Verlag Helvetica Acta, Basel 1997; 333–354, Chap. 21
   Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V., Walker R. Quantitative structure–activity relationships in some cooked food mutagens. Food Addit. Contam. 1995; 12: 715–724
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Parke D. V. The genotoxicity of benzanthracenes: A quantitative structure-activity study. Mutat. Res. 1995; 328: 207–214
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G., Ioannides C., Parke D. V. Inhibition of hepatic aryl hydrocarbon hydroxylase activity by a series of 7-hydroxy coumarins: QSAR studies. Xenobiotica 1994; 24: 829–838
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G., Parke D. V. Molecular orbital-generated QSARs in a homologous series of alkoyresorufins and studies of their inter-active docking with P450s. Xenobiotica 1995; 25: 1355–1369
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. A quantitative structure-activity relationship study on a series of 10 para-substituted toluenes binding to cytochrome P4502B4 (CYP2B4) and also their hydroxylation rates. Biochem. Pharmacol. 1995; 50: 619–625
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Interaction of a series of nitriles with the alcohol inducible isoform of cytochrome P450: Computer analysis of structure-activity relationships. Xenobiotica 1994; 24: 401–408
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Computer graphics analysis of the interaction of alkoxy methylene dioxybenzenes with cytochromes P4501. Toxicol. Lett. 1995; 76: 39–45
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Molecular modelling. Food Chemical Risk Analysis, D. R. Tennant. Chapman & Hall, London 1997; 163–194, Chap. 7
   Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. A retrospective evaluation of COMPACT predictions of rodent carcinogenicity testing from the NTP rodent bioassay results of 40 chemicals. Environ. Health Perspect. 1995; 103: 178–184
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Bird M. G., Parke D. V. Molecular modelling of CYP2E1 enzymes from rat, mouse and man: A possible explanation for the species differences in butadiene metabolism. Toxicology 1997; 118: 93–113
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Validation of a novel molecular orbital approach (COMPACT) to the safety evaluation of chemicals by comparison with salmonella mutagenicity and rodent carcinogenicity data evaluated by the US NCI/NTP. Mutat. Res. 1993; 291: 61–77
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Comparison between rodent carcinogenicity test results of 44 chemicals and a number of predictive systems. Regul. Toxicol. Pharmacol. 1994; 20: 215–222
   PubMed Web of Science ®Google Scholar
• Brown S. J., Raja A. A., Lewis D. F. V. A comparison between COMPACT and HazardExpert evaluations for 80 chemicals tested by the NTP/NCI rodent bioassay. ATLA 1994; 22: 482–500
   Google Scholar
• Bogen K. T. Improved prediction of carcinogenic potencies from mutagenic potencies for chemicals positive in rodents and the Ames test. Environ. Molec. Mutagen. 1995; 25: 37–49
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G. The interaction of some peroxisome proliferators with the mouse liver peroxisome proliferator-activated receptor (ppar): A molecular modelling and quantitative structure-activity relationship study. Xenobiotica 1993; 23: 79–96
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G. A quantitative structure–activity relationship (QSAR) analysis for a series of rodent peroxisome proliferators: Interaction with the mouse liver peroxisome proliferator-activated receptor α (mPPARα). Toxicol. in Vitro 1997; 11: 99–105
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Parker M. G., King R. J. B. Interactions based on molecular modelling of the human estrogen receptor and ligand site-directed mutagenesis and amino acid sequence homology. J. Steroid Biochem. Molec. Biol. 1995; 25: 55–65
   Google Scholar
• Lewis D. F. V. Three-dimensional models of human and other mammalian P450s constructed from an alignment with P450102 (P450bm3). Xenobiotica 1995; 25: 333–366
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G. Molecular modelling of members of the P4502A subfamily: Application to studies of enzyme specificity. Xenobiotica 1995; 25: 585–598
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G. Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: Rationalization of CYP1A substrate specificity in terms of active site amino acid residues. Xenobiotica 1996; 26: 723–753
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Eddershaw P. J., Goldfarb P. S., Tarbit M. H. Molecular modelling of CYP3A4 from an alignment with CYP102: Identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotica 1996; 26: 1067–1086
   PubMed Web of Science ®Google Scholar
• Wiseman H., Lewis D. F. V. The metabolism of tamoxifen by human cytochromes P450 is rationalized by molecular modelling of the enzyme-substrate interactions: Potential importance to its proposed anticarcinogenic/carcinogenic actions. Carcinogenesis 1996; 17: 1357–1360
   PubMed Web of Science ®Google Scholar
• Ioannides C., Parke D. V. Induction of cytochrome P4501 as an indicator of potential chemical carcinogenesis. Drug Metab. Rev. 1993; 25: 485–501
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G. Molecular modelling of omeprazole interactions with cytochrome P450 isozymes is consistent with metabolism in human liver microsomes. Toxicology 1998; 125: 31–44
   PubMed Web of Science ®Google Scholar
• Andersson T., Miners J. O., Tassaneeyakul W., Tassaneeyakul W., Meyer U. A., Birkett D. J. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. Br. J. Clin. Pharmacol. 1993; 36: 521–530
   PubMed Web of Science ®Google Scholar
• Rossi M., Markovitz S., Callahan T. Defining the active site of cytochrome P450: The crystal and molecular structure of an inhibitor, SKF-525A. Carcinogenesis 1987; 8: 881–887
   PubMed Web of Science ®Google Scholar
• Roy M., Fernandez N., Lesca P. Binding characteristics of 4-S proteins from rat and mouse liver. Eur. J. Biochem. 1988; 172: 593–599
   PubMedGoogle Scholar
• Landers J. P., Bunce N. J. The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 1991; 276: 273–287
   PubMed Web of Science ®Google Scholar
• Bresnick E., Houser W. H. The induction of cytochrome P450c by polycyclic hydrocarbons proceeds through the interaction of a 4S cytosolic binding protein. Front. Biotransform. 1990; 2: 62–81
   Google Scholar
• Guengerich F. P. Human cytochrome P450 enzymes. Cytochrome P450, P. R. Ortiz de Montellano. Plenum, New York, 473–535, Chap. 14
   Google Scholar
• Lewis D. F. V. Quantitative structure–activity relationships in a series of alcohols exhibiting inhibition of cytochrome P450 mediated aniline hydroxylation. Chem.-Biol. Interact. 1987; 62: 271–280
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. The calculation of molar polarizabilities by the CNDO/2 method: Correlation with the hydrophobic parameter, log P. J. Comput. Chem. 1989; 10: 145–151
   Web of Science ®Google Scholar
• Hansch C., Leo A. Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York 1979
   Google Scholar
• Sangster J. Octanol–water partition coefficients of simple organic compounds. J. Phys. Chem. Ref Data 1989; 18: 1111–1229
   Web of Science ®Google Scholar
• Hansch C., Bjorkroth J. P., Leo A. Hydrophobicity and central nervous system agents: On the principle of minimal hydrophobicity in drug design. J. Pharmaceut. Sci. 1987; 76: 663–687
   PubMed Web of Science ®Google Scholar
• Suzuki T., Kudo Y. Automatic log P estimation based on combined additive modeling methods. J. Computer-Aided Molec. Des. 1990; 4: 155–198
   PubMed Web of Science ®Google Scholar
• Rekker R. F., ter Laak A. M., Mannhold R. On the reliability of calculated log P values: Rekker, Hansch/Leo and Suzuki approach. Quant. Structure–Activity Relationships 1993; 12: 152–157
   Google Scholar
• Vinter J. G., Davis A., Saunders M. R. Strategic approaches to drug design. 1. An integrated software framework for molecular modelling. J. Computer-Aided Molec. Design 1987; 1: 31–51
   PubMedGoogle Scholar
• Fleming I. Frontier Orbitals and Organic Chemical Reactions. Wiley, New York 1980
   Google Scholar
• Conney A. H. Factors influencing benzo(a)pyrene metabolism in animals and man. Chemical Carcinogenesis, P. O. P. 'O Ts, J. A. Di Paolo. Marcel Dekker, New York 1974; 353–369
   Google Scholar